$5.20
-0.25-4.59%
At Close: -
$5.35
0.152.85%
After Hours: 7:49 PM EDT
15 minutes delayed
Comments
Loading...
Humacyte (HUMA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestHumacyte (NASDAQ:HUMA) Stock Quotes, Forecast and News Summary
Humacyte Stock (NASDAQ: HUMA) stock price, news, charts, stock research, profile.
| Open | $5.44 |
| Close | $5.20 |
| Volume / Avg. | 5.27M / 3.29M |
| Day Range | $5.20 - $5.60 |
| 52 Wk Range | 1.96 - 9.97 |
| Market Cap | $638.33M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | 12.45% |
| Days to Cover | 5.02 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Humacyte Inc
Sector
Health Care
Industry
Biotechnology
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bi...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Humacyte (HUMA) stock?
You can purchase shares of Humacyte (NASDAQ:HUMA) through any online brokerage.
Who are Humacyte (HUMA) competitors?
Other companies in Humacyte’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Celcuity (NASDAQ:CELC), Replimune Group (NASDAQ:REPL), Mesoblast (NASDAQ:MESO) and Opthea (NASDAQ:OPT).
What is the forecast, or price target, for Humacyte (HUMA) stock?
Humacyte has a consensus price target of $12.22.
What is the current price for Humacyte (HUMA)?
The stock price for Humacyte (NASDAQ: HUMA) is $5.3483 last updated September 20, 2024 at 7:49 PM EDT.
Does Humacyte (HUMA) pay a dividend?
There are no upcoming dividends for Humacyte.
When is Humacyte (NASDAQ:HUMA) reporting earnings?
Humacyte’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Humacyte (HUMA) going to split?
There is no upcoming split for Humacyte.
What sector and industry does Humacyte (HUMA) operate in?
Humacyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.